Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Delahaye

Showing results (1-10 of 156) with videos related to

Pageof 16
Sort By:
European Heart Journal|March 31, 1998
Cardiomyoplasty in severe heart failure: where do we stand?F Delahaye, O Jegaden
Presse Medicale (Paris, France : 1983)|December 14, 1996
[Prophylaxis of infectious endocarditis]F Delahaye, C Leport
Archives Des Maladies Du Coeur Et Des Vaisseaux|October 1, 1992
[The facts about cholesterol (condensed translation and comments of the common declaration of AHA and NHLBI)]B Jacotot, F Delahaye
La Revue Du Praticien|April 15, 1992
[Bacterial endocarditis. Etiology, physiopathology, diagnosis, development, prognosis, principles of the treatment]F Delahaye, J Delaye
La Revue Du Praticien|March 21, 1998
[Epidemiology and natural history of cardiac failure]F Delahaye, G de Gevigney
European Heart Journal|April 1, 1997
Which test for detecting accelerated coronary artery disease in the heart transplant patient?F Delahaye, J P Gare
Archives Des Maladies Du Coeur Et Des Vaisseaux|January 19, 1999
[Cardiovascular prevention, primary or secondary, in high risk patients]J L Richard, F Delahaye
Archives Des Maladies Du Coeur Et Des Vaisseaux|April 6, 2002
[Heart failure at the heart of cardiology]J F Aupetit, F Delahaye
Journal of the American College of Cardiology|December 29, 2000
Is the optimal dose of angiotensin-converting enzyme inhibitors in patients with congestive heart failure definitely established?F Delahaye, G de Gevigney
Annales De Medecine Interne|June 30, 2001
[Secondary prevention of coronary artery disease with lipid-lowering drugs]F Delahaye, G De Gevigney
Pageof 16

Showing results (1-10 of 156) with videos related to

Sort By:
Pageof 16
European Heart Journal|March 31, 1998
Cardiomyoplasty in severe heart failure: where do we stand?F Delahaye, O Jegaden
Presse Medicale (Paris, France : 1983)|December 14, 1996
[Prophylaxis of infectious endocarditis]F Delahaye, C Leport
Archives Des Maladies Du Coeur Et Des Vaisseaux|October 1, 1992
[The facts about cholesterol (condensed translation and comments of the common declaration of AHA and NHLBI)]B Jacotot, F Delahaye
La Revue Du Praticien|April 15, 1992
[Bacterial endocarditis. Etiology, physiopathology, diagnosis, development, prognosis, principles of the treatment]F Delahaye, J Delaye
La Revue Du Praticien|March 21, 1998
[Epidemiology and natural history of cardiac failure]F Delahaye, G de Gevigney
European Heart Journal|April 1, 1997
Which test for detecting accelerated coronary artery disease in the heart transplant patient?F Delahaye, J P Gare
Archives Des Maladies Du Coeur Et Des Vaisseaux|January 19, 1999
[Cardiovascular prevention, primary or secondary, in high risk patients]J L Richard, F Delahaye
Archives Des Maladies Du Coeur Et Des Vaisseaux|April 6, 2002
[Heart failure at the heart of cardiology]J F Aupetit, F Delahaye
Journal of the American College of Cardiology|December 29, 2000
Is the optimal dose of angiotensin-converting enzyme inhibitors in patients with congestive heart failure definitely established?F Delahaye, G de Gevigney
Annales De Medecine Interne|June 30, 2001
[Secondary prevention of coronary artery disease with lipid-lowering drugs]F Delahaye, G De Gevigney
Pageof 16